{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-290302","form_type":"8-K","ticker":"AMLX","cik":"0001658551","company_name":"Amylyx Pharmaceuticals, Inc.","filed_at":"2023-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.968074+00:00","generated_at":"2026-06-07T16:14:39.243291+00:00","sec_items":["7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Amylyx CCO Margaret Olinger to depart Dec 31, 2023; search underway","bullets":["Margaret Olinger, Chief Commercial Officer, will leave Amylyx effective end of day Dec 31, 2023.","Company has initiated a search for a new Chief Commercial Officer.","Olinger's departure is not related to any disagreement with Amylyx regarding operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-290302","json":"https://secwatch.observer/filing/0001193125-23-290302.json","markdown":"https://secwatch.observer/filing/0001193125-23-290302.md","text":"https://secwatch.observer/filing/0001193125-23-290302.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/0001193125-23-290302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658551/000119312523290302/d646901d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T16:14:39.243291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}